Related Experiment Video
Updated: Mar 26, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus
Sarah Santos Gonçalves1, Ana Carolina Remondi Souza1, Anuradha Chowdhary2
1Laboratório Especial de Micologia, Disciplina de Infectologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Abstract:
The significant increase in the use of antifungal agents, both for the treatment of candidiasis and invasive aspergillosis and as azole fungicides in agricultural crop protection has resulted in the emergence of resistant clinical isolates, particularly to triazoles and echinocandins. Notably, among isolates that were primarily sensitive to fluconazole such as Candida parapsilosis and Candida tropicalis have witnessed an emerging resistance development. Also for echinocandins, the occurrence of Candida isolates with lower susceptibility to these drugs has been reported, which is possibly due to its broad clinical use. Triazole resistance among Aspergillus fumigatus and other Aspergillus species is commonly found in European and Asian countries. Specific mutations are associated with azole resistance in A. fumigatus and these mutations are now reported globally from six continents. Therefore, we highlight the need to conduct antifungal resistance surveillance studies using clinical isolates of Candida and Aspergillus in different geographical regions and monitoring of the infection rates in distinct population groups for early detection of resistance to these drugs and implementation of efficient policies for infection control and treatment.
Insights
Antifungal resistance is rising in Candida and Aspergillus species due to increased use of antifungal agents and agricultural fungicides. Global surveillance is crucial for early detection and effective infection control policies.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Increased use of antifungal agents for candidiasis and invasive aspergillosis, alongside agricultural azole fungicides, drives antifungal resistance.
- Emerging resistance to triazoles and echinocandins is observed in Candida parapsilosis and Candida tropicalis, previously sensitive to fluconazole.
- Triazole resistance in Aspergillus fumigatus is prevalent globally, linked to specific mutations, necessitating widespread monitoring.
Purpose of the Study:
- To highlight the emergence of antifungal resistance in clinical isolates of Candida and Aspergillus species.
- To emphasize the need for global surveillance of antifungal resistance patterns.
- To inform the development of effective infection control and treatment policies.
Main Methods:
- Analysis of clinical isolates of Candida and Aspergillus species.
- Review of emerging resistance patterns to triazoles and echinocandins.
- Geographical mapping of resistance mutations in Aspergillus fumigatus.
Main Results:
- Significant increase in antifungal resistance, particularly to triazoles and echinocandins.
- Emergence of resistance in Candida species previously sensitive to fluconazole.
- Global spread of azole resistance mutations in Aspergillus fumigatus.
Conclusions:
- Antifungal resistance poses a growing threat, necessitating continuous surveillance.
- Monitoring infection rates and resistance in diverse populations is vital for public health.
- Implementation of robust infection control strategies and treatment policies is urgently required.
Related Concept Videos
Antifungal Agents
Fungal Phylum Ascomycota
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing

